Ignite Creation Date:
2024-05-06 @ 9:05 AM
Last Modification Date:
2024-10-26 @ 12:09 PM
Study NCT ID:
NCT02893072
Status:
UNKNOWN
Last Update Posted:
2019-04-19
First Post:
2016-08-23
Brief Title:
Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study
Sponsor:
The Third Xiangya Hospital of Central South University
Organization:
The Third Xiangya Hospital of Central South University
Study Overview
Official Title:
Individualized Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes
Status:
UNKNOWN
Status Verified Date:
2019-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Gestational diabetes mellitus GDM is one of the most frequent complications of pregnancy that affect between 1 to 14 of population around the world The overall purpose of this study is to determine the efficacy of individualized medical nutrition therapy MNT intervention to reduce and control the development of GDM
Detailed Description:
The number of women with gestational diabetes mellitus had been increasing Maternal GDM has a great impact on both the health of the mothers and the offspring Antenatal lifestyle interventions in particular dietary intervention appear to be feasible to improve maternal GDM and weight gain To the best of our knowledge there has been no such trial examining the feasibility of MNT intervention in pregnant women in Hunan province The aim of this study is to evaluate the efficacy of individualized MNT intervention to reduce and control the development of GDM This is a prospective study 500 patients who meet inclusion and exclusion criteria will be included The changes of glucose and weight will be evaluated every two weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None